Change in Hepatitis B Virus Large Surface Antigen Variant Prevalence 13 Years after Implementation of a Universal Vaccination Program in China by Bian, T. et al.
Change in Hepatitis B Virus Large Surface Antigen Variant Prevalence
13 Years after Implementation of a Universal Vaccination Program in
China
Tao Bian,a,b Hongxia Yan,a,c Liping Shen,a Feng Wang,a Shuang Zhang,a Yanqiang Cao,d Shuo Zhang,a Yong Zhang,a Shengli Bia
National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping District, Beijing, Chinaa; Division of Molecular
Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USAb; Bureau for Health Inspection and Supervision of Chaoyang
District, Chaoyang District, Beijing, Chinac; Hebei Entry-Exit Inspection and Quarantine Bureau, Shijiazhuang, Chinad
A nationwide hepatitis B virus (HBV) vaccination program was implemented in China starting in 1992. To study the change in
HBV variant prevalence with massive immunization, large HBV surface protein (LHBs) genes from HBV surface antigen
(HBsAg)-positive sera were amplified and sequenced. The prevalences of LHBs mutants were compared between the 1992 and 2005
surveys in child and adult groups. The prevalence of “” determinant mutants in the children increased from 6.5% in 1992 to
14.8% in 2005, where the G145R mutant occurred most frequently. In contrast, mutation frequencies showed little difference
between 1992 (9.4%) and 2005 (9.9%) in adults. Moreover, compared to the 1992 survey, the child group surface (S) protein mu-
tation frequency specifically increased (P  0.005) in the 2005 survey, but the pre-S region mutation frequency did not show a
significant difference (P > 0.05). However, the mutation frequency in the adult group increased in both the pre-S and S regions.
Furthermore, the frequencies of the disease-related pre-S2 deletion and start codon mutations were significantly higher in the
adult groups than in the child groups in both the 1992 and 2005 surveys (P < 0.01). Massive immunization enhances the HBV S
protein mutation; the prevalence of LHBs mutants, particularly disease-related mutants, tends to increase with patient age.
Hepatitis B virus (HBV) infection is a serious public healthproblem worldwide and a major cause of hepatitis, cirrhosis,
and hepatocellular carcinoma (HCC) (1). An estimated 350 mil-
lion people are living with chronic hepatitis B worldwide (2). In
China, a national serosurvey in 1992 revealed that the prevalence
of hepatitis B surface antigen (HBsAg) was 9.8% in the general
population (3). The most recent national serosurvey, in 2006,
demonstrated that the HBsAg carrier rate is 7.2%, and the number
of chronic HBV carriers is estimated to be 9.3 million (3, 4).
China began infant vaccine injections in national disease sur-
veillance points (DSP) as early as 1986, and the four provinces in
the current study were also to perform infant vaccinations at that
time (5). In 1992, China formally recommended routine immu-
nization with the hepatitis B virus vaccine for infants. Since then,
the massive vaccination program has effectively decreased the risk
of HBV infection, and the rate of HBsAg-positive children has
significantly declined. Among children 5 years of age, the prev-
alence of HBsAg has dramatically decreased from 9.67% (1992) to
0.96% (2006). It is estimated that 80 million children are free from
HBV infection due to the vaccination program (3).
While universal infantile HBV vaccination is very efficacious,
an increase in the mutant prevalence or “vaccine escape muta-
tion” after immunization posed a potential threat to the long-term
success of massive vaccination (6–8). Hsu et al. studied the prev-
alence of HBV variants in children in Taiwan and demonstrated
that universal vaccination had accelerated the accumulation of
HBsAg “” determinant mutants (9). The  determinant is a com-
mon immunodominant region shared by different genotypes of
HBV, which spans amino acids (aa) 124 to 147 of the S protein
(10). The  determinant is hydrophilic and is believed to be in the
form of two major loops with cysteine-disulfide bonds (11). It is
well documented that neutralizing antibodies induced by immu-
nization against hepatitis B virus infection are targeted to the con-
formational epitopes of the  determinant (12). The substitution
mutations within the surface protein, particularly in the  do-
main, allow HBV replication in vaccinated subjects, since anti-
bodies induced by vaccines do not recognize crucial changes in the
surface antigen domain (8).
Differing from the mutations in the S region that are related to
vaccine escape, pre-S mutations were studied for their correlation
with the progression of liver disease (13). Particularly, pre-S2 de-
letion and pre-S2 start codon mutations were frequently detected
in cases of liver cirrhosis and HCC (14). The deletion always clus-
tered at the site of immunologic epitopes (13). Furthermore,
pre-S2 start codon mutations can impair secretion of virus. The
accumulation of viral protein induces host liver cell endoplasmic
reticulum stress. Such an effect is a possible mechanism for the
development of HCC, as proven in studies with transgenic mice
(15).
Here, large HBV surface protein (LHBs) mutations were stud-
ied to evaluate the impact of universal vaccination on HBV mu-
tation in China. The changes in LHBs mutant prevalences be-
tween children and adults were compared as well. Some
meaningful observations provide valuable information about vi-
rus mutation and broaden our understanding of HBV mutation
occurrence.
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MATERIALS AND METHODS
Patients and methods. Two seroepidemiological studies were conducted
with multistage cluster random sampling in the same four national DSPs
during the years 1992 and 2005: Long An in Guangxi province (GX),
Zheng Ding in Hebei province (HB), Xiang Tan in Hunan province (UN),
and Luo He in Henan province (HN). The DSP was selected by the Chi-
nese Center for Disease Control and Prevention to be representative of the
population. Each DSP consists of one county. In the 1992 survey, persons
1 to 59 years old residing for more than 6 months in the county at the time
of the survey were selected. In the 2005 survey, a house-to-house investi-
gation was completed in the DSP by trained staff. The age of participants
ranged from 3 months to 94 years. People who had resided in the DSP for
16 months at time of the survey visit were selected. The complete selection
methods were described previously (16, 17). The populations recruited in
the seroepidemiological surveys were divided into the following four
groups: (i) children younger than 18 years of age in the 1992 survey (born
during 1974 to 1992), (ii) children younger than 18 years of age in the 2005
survey (born during 1986 to 2005), (iii) adults aged between 35 and 55
years in the 1992 survey (born during 1937 to 1957), and (iv) adults aged
between 35 and 55 years in the 2005 survey (born during 1950 to 1970).
Sera from UN was lacking for both the 1992 and 2005 adult groups. The
demographic characteristics of the subjects in the study are summarized
in Table 1. The adult demographic characteristics and economic condi-
tions at these points are not statistically different from those of the whole
country. GX and UN are southern provinces, and HB and HE are north-
ern provinces. The study population is “Han” in Hunan, Hebei, and
Henan provinces, while the study population in Guangxi province is
mostly “Zhuang.”
Serology analysis. All serum specimens were tested in the National
Hepatitis Laboratory, Institute for Viral Disease Control and Prevention
(IVDC), Chinese Center for Disease Control and Prevention (CDC). The
presence of HBsAg was determined by using a solid-phase radioimmuno-
assay (SPRIA). A ratio of the HBsAg level in the sample to that in the
negative control (S/N ratio) of 10 was defined as positive. After assaying
for serum HBV markers in each participant, the sera were stored at 30°C
for later analysis.
Viral DNA extraction and sequencing. HBsAg-positive sera were se-
lected for extraction of viral DNA by using a viral DNA minikit (Qiagen,
German). For sequence analysis, the LHBs genes were amplified by using
nested PCR. First-round PCR primers were 5=-GGGTCACCATATTCTT
GGG-3= (nucleotides [nt] 2850 to 2868) and 5=-CAAAGACAAAAGAAA
ATTGG-3= (nt 803 to 822). PCR was performed under the following con-
ditions: 95°C for 5 min, 95°C for 35 s, 58°C for 35 s, and 72°C for 2 min for
30 cycles and finally 72°C for 7 min. Second-round PCR primers were
5=-GAACAAGAGCTACAGCATGGG-3= (nt 2868 to 2888) and 5=-GGT
AAAAAGGGACTCAAGATG-3= (nt 775 to 795), and the same PCR con-
ditions as those for the first-round reaction were used. All necessary pre-
cautions to prevent cross-contamination were taken, and negative
controls were included in each assay. The nucleotide sequences of the
amplified products were determined directly by using fluorescence-la-
beled primers (TaKaRa Bio Inc., Japan).
HBV genotyping and mutation identification. HBV genotypes were
determined by phylogenetic analysis using the neighbor-joining method
(MEGA, v3.1), including 8 HBV strains of different genotypes obtained
from GenBank with the following accession numbers: X02763 (genotype
A), D00300 (genotype Ba), AB073858 (genotype Bj), AB03556, M12906,
X52939 (genotype C), AB048704 (genotype Caus), X02496 (genotype D),
X02496 (genotype D), X75657 (genotype E), AF160501 (genotype G),
X75858 (genotype F), and AY050454 (genotype H). The reliability of the
phylogenetic tree was tested by using the bootstrap test with 1,000 repli-
cates (Fig. 1 to 4). The envelope amino acid sequence was determined by
translation of the nucleotide sequence according to the LHBs open read-
ing frame (ORF). The genotype B or C sequences were aligned with stan-
dard LHBs sequences. The mutations in target sequences were identified
and recorded, which did not align with any of the standard sequences.
Data analysis. Data are presented as means  standard deviations
(SD), proportions, or rates (95% confidence intervals [CIs]). To compare
the values between the groups, the 2 or Fisher exact test was applied to
analyze categorical variables, and Student t tests and Mann-Whitney U
tests were used for continuous variables with normal and skewed distri-
butions, respectively. All statistical tests were 2 sided. A P value of 0.05
was considered statistically significant. All statistical analyses were per-
formed by using SPSS 13.0 for Windows (SPSS Inc., IL).
RESULTS
Characteristics of the study population. During the 1992 and
2005 investigations, a total of 8,862 people were enumerated, who
came from the same national DSP. There were 6,421 children
younger than 18 years old and 2,421 adults between the ages of 35
and 55 years (Table 1). After the SPRIA assay, HBsAg-positive sera
were collected to extract HBV DNA and perform PCR. More than
1,100 base pair LHBs gene sequences were amplified. After the
PCR production sequencing, the final numbers and percentages
of acquired sequences were determined and are listed in Table 2.
The “” determinant mutants in HBsAg-positive children.
To investigate the  determinant mutant virus prevalence in 1992,
157 HBsAg-positive children from four different DSPs were stud-
ied for the presence of HBV DNA by PCR (Table 2). Eventually,
138 sera were seropositive for HBV DNA. Among the 138 ac-
quired LHBs sequences, 9 HBV DNA-positive children in 1992
harbored the mutations. The percentage of occurrence of  deter-
minant mutations was 6.5% (95% CI, 2.4 to 10.6%). In the 2005
survey, 116 HBsAg-positive children were studied for the presence
of HBV DNA by PCR. Fifteen children harbored  determinant
mutant virus among the 101 children who harbored a sequenced
virus. One child harbored a variant HBV strain that had double
TABLE 1 Demographic characteristics of the study population
Characteristic
Value(s) for children Value(s) for adults
GX UN HB HN Total GX HB HN Total
1992 survey
No. (%) of male patients 143 98 184 458 883 (48.4) 109 192 118 419 (49.1)
No. (%) of female patients 136 100 191 515 942 (51.6) 108 200 128 433 (50.9)
Mean age (yr)  SD 9.4 7.6 9.8 7.2 8.1  2.3 40.1 42.3 41.9 41.7  3.7
2005 survey
No. (%) of male patients 331 409 599 913 2,252 (49.0) 138 211 427 776 (48.7)
No. (%) of female patients 343 421 614 964 2,344 (51.0) 147 202 464 813 (51.3)
Mean age (yr)  SD 14.3 13.7 10.9 11.6 12.2  2.6 43.1 41.1 42.3 41.9  3.4
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mutations. Therefore, the  determinant mutant virus percentage
for the 2005 survey was 14.8% (95% CI, 7.9 to 21.8%) (15 out of
101), which was significantly higher than that for the 1992 survey
(2  4.48; P  0.03). Detailed backgrounds of the children who
harbored mutant virus are summarized in Table 3.
FIG 2 Phylogenetic analysis of children from the 2005 survey. The first two
letters represent the name of the province.
FIG 1 Phylogenetic analysis of children from the 1992 survey. The first two
letters represent the name of the province.
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FIG 3 Phylogenetic analysis of adults from the 1992 survey. The first two letters represent the name of the province.
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The  determinant mutants in HBsAg-positive adults. As a
control, the  determinant mutants virus statuses in adult groups
were investigated, because massive vaccination has never been
performed for adults. HBsAg-positive adults from the 1992 and
2005 surveys were studied, and the harbored viruses were ampli-
fied and sequenced. In the 1992 survey, 53 LHBs genes were suc-
cessfully sequenced from 78 HBV-positive sera. A total of 5 se-
quences with  determinant mutations were detected. Thus, the 
determinant mutation occurrence rate was 9.4% (95% CI, 1.6 to
17.3%) in the 1992 survey. In the 2005 survey, 91 LHBs genes
successfully sequenced from 112 HBV-positive sera. Subse-
quently, 9 sequences tested positive for a mutation in the  deter-
minant, and the mutation occurrence rate was 9.9% (95% CI, 3.8
to 16.0%). Two variant HBV sequences had double and triple
mutations. Detailed backgrounds of adults harboring mutant vi-
rus are summarized in Table 4. The percentages of  determinant
mutant virus in the 1992 and 2005 surveys were not significantly
different (2  0.02; P  0.9).
Frequencies and sites of  determinant mutations are differ-
ent between children and adults. In the 1992 child group, the
most frequent sequence mutation site was T126 (3 out of 138),
and only one strain had a G145A mutation. However, in the 2005
child group, the most frequent sequence mutation site was G145
(6 out of 101), and 5 mutations occurred at T126 (Fig. 5B). Even
though there was no significant difference, the T126 mutation
rates were higher in 2005 than in the 1992 survey (Fig. 5B). It was
reported that the T126A mutant was found in an infant with
chronic infection despite immunoprophylaxis, meaning that
T126 seems to affect the recognition properties of the surface an-
tigen (18). G145 mutations were of relatively low frequency in the
1992 child group and the two adult groups (Fig. 5). However, its
frequency significantly increased in the 2005 child group (P 
0.04). As the most commonly found mutant, G145R has been
reported to alter the projecting loop (residues 139 to 147) of the 
determinant. Consequently, neutralizing antibody induced by
vaccination no longer recognizes the mutated epitope, which is
hence termed a vaccine escape mutant (11, 19).
Importantly, the frequently mutated sites in the adult groups
were different from those in the child groups. Residues M133 and
F134 have high mutation frequencies in adults (Fig. 5C), and such
mutations are implicated in the development of hepatocellular
carcinoma (20, 21). Both of the mutations are located in the first
loop of the  determinant (residues 124 to 138). Furthermore, the
M133T mutation can change HBV secretion (22). Lastly, the adult
group’s mutation panel is similar to the one previously reported
for nonimmunized Chinese carriers (23).
Change in the LHBs amino acid substitution frequency in
children. The substitution mutations in LHBs were identified ac-
cording to standard strains of genotype B or C. Child group mu-
tations were compared and analyzed between the 1992 and 2005
surveys. In the 1992 survey, there were 46 genotype B sequences,
with a total number of 7,314 residues in the pre-S region. Among
the 7,314 residues, 42 substitution mutations (0.58%) occurred.
In 2005, there were 44 mutations out of 3,975 total residues
(0.73%) in the same region. Likewise, in the 1992 survey, 46 ge-
notype B sequences had 9,660 total residues in the S region, and 8
mutations (0.08%) were identified. In the 2005 survey, 8 muta-
tions were found out of 5,250 residues (0.15%). For genotype C,
121 mutations were identified out of 12,879 residues (0.94%) and
100 mutations were identified out of 9,381 (1.07%) residues in the
FIG 4 Phylogenetic analysis of adults from the 2005 survey. The first two
letters represent the name of the province.
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pre-S region in the 1992 and 2005 surveys, respectively. In the S
region, the mutation frequencies were 0.16% (27/17,010) in the
1992 survey and 0.28% (35/12,390) in the 2005 survey (Table 5).
The mutation sites and frequencies are summarized in Fig. 6.
Combining the genotype B and the genotype C results, there were
no differences in the pre-S region between the 1992 (163/20,193;
0.81%) and 2005 (129/13,356; 0.97%) surveys (2  2.35; P  0.13).
However, a significant increase in the mutation frequency was shown
in the S region by comparing the 1992 (0.13%) and 2005 (0.24%)
surveys (2  7.65; P  0.005). Therefore, the child group of the 2005
survey had a specifically higher mutation frequency in the S region.
Change of the LHBs amino acid substitution frequency in
adults. The LHBs mutations in adult groups were also investi-
gated and compared between the 1992 and 2005 surveys. For ge-
notype B, the mutation frequency in the 1992 survey was 0.90%
(20/2,226) in the pre-S region, versus 0.91% (16/1,749) in the
TABLE 2 Prevalence of HBV  determinant variants from HBsAg-postive personsa
Characteristic
No. of children from indicated province
Total no. (%)
of children
No. of adults from indicated
province
Total no. (%)
of adultsGX UN HB HN GX HB HN
1992 survey
Collected sera 279 198 375 973 1,825 214 392 246 852
HBsAg sera 29 17 31 80 157 (8.6) 22 33 23 78 (9.2)
Acquired sequences 24 16 26 72 138 (87.9) 14 23 16 53 (69.2)
Variants 2 3 2 2 9 (6.5b) 1 2 2 5 (9.4)
2005 survey
Collected sera 674 832 1,213 1,877 4,596 285 413 891 1,589
HBsAg sera 22 19 28 47 116 (2.5) 25 26 61 112 (7.1)
Acquired sequences 19 17 24 41 101 (88.8) 19 20 52 91 (81.2)
Acquired sequences 7 3 2 3 15 (14.8b) 4 3 2 9 (9.9)
a Percentage calculated as the lower row number/the upper row number.
b 2  4.48; P  0.03.
TABLE 3 Characteristics of HBsAg  determinant variants among children from seroepidemiological surveys in 1992 and 2005a
Patient Variant Age (yr) Sex Genotype Serotype HBeAg result
1992 survey
GX-1 T125M 11 M C adw #
GX-2 T126S 10 M B adw #
UN-1 T126A 5 M B adw #
UN-2 Q129H 13 M B adw #
UN-3 T143M 2 M B adw #
HN-1 G130R 7 F D ayw #
HN-2 T131N 3 M B adw #
HB-1 I126S 10 F C adr #
HB-2 G145A 14 F C adr #
Total 8.33  4.3 6 M/3 F 3 C/5 B/1 D 6 adw/2 adr/1 ayw
2005 survey
GX-1 T125I 1 F B adw 
GX-2 T126A 7 M C adw 
GX-3 T126A 16 M C adw 
GX-4 T126A 16 M C adw 
GX-5 T126N 7 F C adr 
GX-6 G145A 14 M C adr 
GX-7 G145A 13 F C adr 
UN-1 T131I 17 M B adw 
UN-2 G145R 11 M B adw 
UN-3 G145R 14 F B adw 
HN-1 G145A 8 M C adr 
HN-2 I126S 10 F C adr 
HN-3 Q129H 12 M B adw 
HB-1 T126S/G130N 16 F C adr 
HB-2 G145R 6 F B adw 
Total 11.2  4.6 8 M/7 F 9 C/6 B 9 adw/6 adr 11 /4 
a Abbreviations: M, male; F, female; HBeAg, HBV e antigen; #, not performed; , negative; , positive.
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2005 survey. In the S region, the mutation frequencies were 0.49%
and 0.34% in the 1992 and 2005 surveys, respectively. For geno-
type C, 30 mutations were identified in the pre-S region from
2,862 residues (1.05%) in 1992, compared to 151 mutations from
9,699 total residues (1.53%) in the 2005 survey. In the S region, the
mutation frequencies were 0.48% in the 1992 survey and 0.62% in
the 2005 survey.
Combining the results for genotype B and genotype C, the
mutation frequencies in the 2005 survey were significantly higher
than those in the 1992 survey in both the pre-S region (2  5.92;
P  0.02) and the S region (2  4.52; P  0.03) (Table 5). There-
fore, the mutation frequencies in the 2005 adult group were higher
than those in the 1992 survey for both the pre-S and S regions.
Pre-S2 deletion and start codon mutation frequencies were
significantly higher in the adult group than in the child group.
Previous studies have shown that pre-S2 deletion and start codon
mutations are related to progressive liver disease (13, 24). There-
fore, the prevalences of pre-S2 deletion and start codon mutations
were compared between the child and adult groups. In both the
1992 and 2005 child groups, neither pre-S2 start codon mutations
nor deletions were observed. However, in the adult group, pre-S2
start codon mutation occurrence frequencies were 6.3% (2 out of
32) in 1992 and 8.2% (6 out of 73) in the 2005 survey (Table 6).
The deletion mutation occurrence frequency was identical to the
start codon mutation frequency. Specific pre-S2-deleted residues
(counting from the start codon of LHBs) found were residues 123
to 141 (1992), 130 to 141 (1992), 127 to 141 (2 strains in 2005), 132
to 141 (2 strains in 2005), 132 to 143 (2005), and 140 to 144
(2005). Moreover, three strains had both deletion and start codon
mutations. These results demonstrate a significantly high increase
in the frequency of occurrence of pre-S2 deletion and start codon
mutations among the adult group (P  0.01).
DISCUSSION
The long-term change of HBV LHBs variants has never been stud-
ied by large-scale community-based population surveys in China.
FIG 5 Mutations in the  determinant. (A) Schematic representation showing
LHBs and amplified sequences. The start and end residues of the pre-S1, pre-
S2, and S proteins and the  determinant of HBsAg are indicated. The bottom
rectangle represents the amplified sequence, with the start and end positions
labeled. (B) Mutations in the  determinant of child groups. (C) Mutations in
the  determinant of adult groups. The y axis represents the mutation ratio
(number of mutations/number of all indicated sequences). The x axis repre-
sents the amino acid site of the S protein where the indicated mutations oc-
curred.
TABLE 4 Characteristics of HBsAg  determinant variants from adults in seroepidemiologic surveys in 1992 and 2005a
Patient Variant Age (yr) Sex Genotype Serotype HBeAg result
1992 survey
GX-1 T126A 40 M B adw #
HN-1 T126A 38 M B adw #
HN-2 T126C 38 F C adr #
HB-1 T131A 52 M C adr #
HB-2 M133L 39 M B adw #
Total 41.4 4 M/1 F 2 C/3 B 3 adw/2 adr
2005 survey
GX-1 T125I 34 M B adw 
GX-2 M133I 24 F C adr 
GX-3 M133T/T140I 35 F C adw 
GX-4 G145K 36 M C adw 
HN-1 M133T 54 F C adr 
HN-2 I126S/S132F/M134I 21 M C adr 
HB-1 F134Y 57 M C ayw 
HB-2 M133T 57 M C adr 
HB-3 F134Y 58 F C adr 
Total 41.8 5 M/4 F 8 C/1 B 3 adw/5 adr/1 ayw 6 /3 
a Abbreviations: M, male; F, female; HBeAg, HBV e antigen; #, not performed; , negative; , positive.
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Taking advantage of 1992 and 2005 serosurveys before and after
universal immunization, we provided a meaningful comparison
of LHBs variant HBsAg-seropositive populations within the same
area. Convincing evidence for the influence of universal vaccina-
tion on the emergence of  determinant mutants comes from the
following observations. (i) The prevalence of  determinant mu-
tants in the child group increased from 6.5% in 1992 to 14.8% in
2005. The results are consistent with a previous study of vacci-
nated children in Taiwan (9). To further confirm the results, we
also detected the mutations in the adult group within same area as
a control. We assumed that massive immunization had little in-
fluence on their mutations. As expected, the prevalence of  de-
terminant mutants in the adult groups showed little difference
between the 1992 (9.4%) and 2005 (9.9%) surveys. Comparing the
child groups with the adult groups, the difference in the mutation
frequency provides novel evidence that massive immunization
enhanced  determinant mutations. (ii) An increased number of
mutated residues from the 2005 child group occurred at impor-
tant residues that are neutralizing epitopes, such as G145 and
T126. Although the G145R variant was reported to sparsely spread
because of the lower serum HBV DNA level (25), the G145R mu-
tation is still the most common mutation in the child group from
the 2005 survey. The high prevalence is highly associated with
vaccination selection (26, 27). On the contrary, in the adult group,
the mutation profile is different, and the most frequently occur-
ring mutations clustered at the first loop of the  determinant,
such as M133 and T134. Such mutations are associated with virus
secretion and disease development (28–30). Thus, the results
showed that the child group mutations are under the pressure of
vaccine immunization; however, adult group mutations are nat-
ural occurrences and disease related. In addition, the status of
nucleoside analogue-resistant mutations was also determined.
However, no drug-resistant mutants were discovered in either the
child or adult groups (Table 7).
There have been limited numbers of epidemiology studies that
investigated pre-S region substitution mutations. There is a high
mutation frequency in the pre-S region relative to S region con-
servation. Some mutations are genotype related, particularly in
genotype C, which has more subgenotypes in China (31). The
HBV genotypes are highly endemic in China. Southern China has
a higher genotype B prevalence, while genotype C is found mainly
in the north (32). To avoid genotype-specific mutations, the se-
quences were aligned with strains of multiple genotypes. Follow-
ing the statistical analysis, the following intriguing results were
observed. (i) Children in the 2005 survey had a specifically high
mutation frequency in the HBV S region. Results for genotypes B
and C were consistent. This is the first demonstration that only S
region and not pre-S region mutation frequencies have signifi-
cantly increased (2  7.65; P  0.01). Because children were
universally vaccinated with the HBV vaccine, comprised of the
HBV S protein, the specific increase in the S region mutation
frequency in the child group of the 2005 survey is strong evidence
for immunization enhancing mutation of the S region. In the
adult group, the genotype C mutation frequency also increased
between the 1992 and 2005 surveys; however, the increase is non-
specific, and the frequency of mutations in the pre-S region even
had a slightly higher increase than in the S region. A possible
reason for this is a difference in the prevalent HBV strains between
the 1992 and 2005 surveys. (ii) HBV sequence mutation profiles
between child and adult groups are different (Table 5). There were
higher mutation frequencies in the adult group than in the child
group. Because perinatal transmission is the primary way of infec-
tion in China (33), adult carriers always endure a longer time of
infection. The results demonstrated that the HBV mutation fre-
quency increased during the long course of infection. The results
also suggested that the age of the individual upon infection is an
important factor affecting the outcome of hepatitis B virus infec-
tion. The percentage of acquired sequences from HBsAg-positive
sera was lower in the adult groups than in the child groups (Table
2). This is more evidence of the higher mutation frequency in
adult groups.
Pre-S deletion mutations are correlated with progressive liver
disease development (15). Pre-S2 deletion and start codon muta-
tions have particularly shown a high prevalence in occult carriers
and cirrhosis and HCC patients (22, 23). It is a very interesting
observation that pre-S2 start codon mutation and deletion fre-
quencies were significantly higher in the adult groups than in the
child groups. In fact, no pre-S2 mutation was observed in the child
group. In the adult group, the pre-S2 deletion mutations were
clustered at T cell-recognized epitopes (13). This phenomenon
may demonstrate that most of the pre-S mutations occurred
spontaneously and evolved during long-term coexistence with the
TABLE 5 Amino acid substitution frequencies in S and pre-S regionsa
Parameter
Value(s) for genotype B Value(s) for genotype C Total value(s)
1992 2005 2 P 1992 2005 2 P 1992 2005 2 P
Children
Total no. of sequences 46 25 81 59 127 84
No. of pre-S residues 7,314 3,975 12,879 9,381 20,193 13,356
No. (%) of pre-S mutations 42 (0.58) 29 (0.73) 0.99 0.32 121 (0.94) 100 (1.07) 0.88 0.35 163 (0.81) 129 (0.97) 2.35 0.13
No. of S residues 9,660 5,250 17,010 12,390 26,670 17,640
No. (%) of S mutations 8 (0.08) 8 (0.15) 1.54 0.22 27 (0.16) 35 (0.28) 5.22 0.02* 35 (0.13) 43 (0.24) 7.65 0.005**
Adults
Total no. of sequences 14 11 18 62 32 73
No. of pre-S residues 2,226 1,749 2,862 9,858 5,088 11,607
No. (%) of pre-S mutations 20 (0.90) 17 (0.97) 0.06 0.81 30 (1.05) 151 (1.53) 3.70 0.05 50 (0.98) 168 (1.45) 5.92 0.015*
No. of S residue 2,940 2,310 3,780 13,020 6,720 15,330
No. (%) of S mutations 9 (0.31) 6 (0.26) 0.10 0.75 13 (0.34) 77 (0.59) 3.37 0.07 22 (0.33) 83 (0.54) 4.52 0.034*
a Percentage calculated as the lower row number/the upper row number. *, P  0.05; **, P  0.01.
HBV Variants in China
November 2013 Volume 87 Number 22 jvi.asm.org 12203
host body but not through interpersonal infection. However, how
HBV evolved with the host is an intriguing question, which may be
related to liver cell maturity or host hormone level changes. Mean-
while, this result demonstrated that the LHBs mutation frequency
increased in direct relation to the course of infection.
While some meaningful conclusions can be drawn from this
comparison, there are some limitations of our study. First, only
HBsAg-positive patients were enrolled in the study. Previous
studies demonstrated that populations with HBsAg-negative but
other positive marker profiles harbored even more mutations (9).
Therefore, more studies will be conducted to investigate muta-
tions in other serogroups in the future. Second, the vaccination
backgrounds of the children were lacking in some areas, particu-
larly in the 1992 survey. However, because massive vaccination in
DSPs was initiated in 1986, the percentage of vaccinated children
in 2005 was dramatically higher than that in 1992. According to
the GX province record in the 2005 survey, in the population 20
years old, 85.9% of subjects were vaccinated for HBV, whereas
only 3.8% of subjects aged 20 years had received HBV vaccina-
tion (16). Therefore, we investigated the mutation frequency of an
FIG 6 Distribution of LHBs substitution mutations. (A) Mutation of genotype B in child groups (1992 survey, n  46; 2005 survey, n  25). (B) Mutation of
genotype B in adult groups (1992 survey, n  14; 2005 survey, n  11). (C) Mutation of genotype C in child groups (1992 survey, n  81; 2005 survey, n  59).
(D) Mutation of genotype C in adult groups (1992 survey, n  18; 2005 survey, n  62). The y axis represents the mutation ratio (number of mutations/number
of all indicated sequences). The x axis represents the amino acid site of the LHBs protein where the indicated mutations occurred. The yellow line represents the
pre-S1 region. The blue line represents the pre-S2 region. The black line represents the S region.






No. of sequences 127 32
No. (%) of pre-S2 start codon mutations 0 2 (6.3) 0.04
No. (%) of pre-S2 deletion mutations 0 2 (6.3) 0.04
2005
No. of sequences 84 73
No. (%) of pre-S2 start codon mutations 0 6 (8.2) 0.01
No. (%) of pre-S2 deletion mutations 0 6 (8.2) 0.01
Total
No. of sequences 211 105
No. (%) of pre-S2 start codon mutations 0 8 (7.6) 0.01
No. (%) of pre-S2 deletion mutations 0 8 (7.6) 0.01
a Percentage calculated as number of mutations/number of sequences. Data analysis
was done by Fisher’s exact test.
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adult group as control and showed that the mutation frequency
was no different between the 1992 and 2005 surveys. Thus, we still
can draw the conclusion that the massive vaccination program
enhances mutations. Lastly, the PCR products were directly se-
quenced in the study. This method ignored quasispecies muta-
tions; however, the method can determine that the sequence is the
dominant strain.
In conclusion, our study provides information on a long-term
basis for both child and adult populations and demonstrates some
characteristics of virus evolution and mutation under massive
vaccination. The mutation distribution differences were pre-
sented in LHBs, particularly in the pre-S region, between adult
and child groups. The results showed that such mutations are due
to long-term persistent infection, which can explain that the time
of infection is correlated with disease prognosis.
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Lamivudine V173L V173A (HN) N N N
I169T N N N N
M204V/I N N N N
L180M N N N N
Famciclovir L180M N N N N
Adefovir A181V N N N N
I169 N N N N
Entecavir T184 N N N N
S202 N N N N
Tenofovir A194T N N N N
a N, no mutations were detected.
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